HOOKIPA Pharma Inc. (HOOK)
OTCMKTS
· Delayed Price · Currency is USD
0.890
+0.003 (0.36%)
At close: Dec 5, 2025
HOOKIPA Pharma Revenue
HOOKIPA Pharma had revenue of $2.00M in the quarter ending March 31, 2025, a decrease of -94.52%. This brings the company's revenue in the last twelve months to $9.35M, down -82.54% year-over-year. In the year 2024, HOOKIPA Pharma had annual revenue of $43.95M with 118.32% growth.
Revenue (ttm)
9.35M
Revenue Growth
-82.54%
P/S Ratio
1.22
Revenue / Employee
110.01K
Employees
87
Market Cap
11.36M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 122.89M |
| Glass House Brands | 196.17M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 937.00K |
| Silence Therapeutics | 25.83M |
| Global Cord Blood | 196.10M |
| Zomedica | 29.45M |
HOOKIPA Pharma News
- 5 weeks ago - Gilead Sciences (GILD) Acquires Key Assets from HOOKIPA Pharma - GuruFocus
- 5 weeks ago - HOOKIPA Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead - GlobeNewsWire
- 5 months ago - HOOKIPA Pharma to delist from Nasdaq and liquidate following Gilead asset sale - Seeking Alpha
- 5 months ago - HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock - GlobeNewsWire
- 10 months ago - HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”) - GlobeNewsWire
- 11 months ago - Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA - GlobeNewsWire
- 11 months ago - HOOKIPA Pharma Inc - FORM 8 (OPD) - GlobeNewsWire
- 11 months ago - HOOKIPA Pharma Announces Notice to Shareholders Regarding U.K. Disclosure Requirements - GlobeNewsWire